Literature DB >> 11839824

Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38.

Janice C Wolfman1, Todd Palmby, Channing J Der, Alan Wolfman.   

Abstract

Cellular N-Ras provides a steady-state antiapoptotic signal, at least partially through the regulation of phosphorylated Akt and Bad levels. Fibroblasts lacking c-N-Ras expression are highly sensitive to the induction of apoptosis by a variety of agents. Reduction of pBad and pAkt levels using a phosphatidylinositol 3-kinase inhibitor was not sufficient to sensitize the control cell population to the high level of apoptosis observed in the N-Ras knockout cell lines, suggesting that c-N-Ras provides at least one other antiapoptotic signal. Stimulation of the control cells with apoptotic agents results in a transient increase in Jun N-terminal protein kinase (JNK)/p38 activity that decreased to baseline levels during the time course of the experiments. In all cases, however, sustained JNK/p38 activity was observed in cells lacking c-N-Ras expression. This correlated with sustained levels of phosphorylated MKK4 and MKK3/6, upstream activators of JNK and p38, respectively. Mimicking the sustained activation of JNK in the control cells did result in increasing their sensitivity to apoptotic agents, suggesting that prolonged JNK activity is a proapoptotic event. We also examined the potential downstream c-N-Ras targets that might be involved in regulating the duration of the JNK/p38 signal. Only the RalGDS 37G-N-Ras protein protected the N-Ras knockout cells from apoptosis and restored transient rather than sustained JNK activation. These data suggest that cellular N-Ras provides an antiapoptotic signal through at least two distinct mechanisms, one which regulates steady-state pBad and pAkt levels and one which regulates the duration of JNK/p38 activity following an apoptotic challenge.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839824      PMCID: PMC134687          DOI: 10.1128/MCB.22.5.1589-1606.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  137 in total

1.  Akt is more than just a Bad kinase.

Authors:  A Khwaja
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

Review 2.  Cell cycle: routine role for Ras.

Authors:  J Downward
Journal:  Curr Biol       Date:  1997-04-01       Impact factor: 10.834

3.  Autocrine signaling through Ras prevents apoptosis in vascular smooth muscle cells in vitro.

Authors:  T Miyamoto; J C Fox
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

4.  Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8(+) but not CD4(+) T cells.

Authors:  C Merritt; H Enslen; N Diehl; D Conze; R J Davis; M Rincón
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase.

Authors:  M P Scheid; K M Schubert; V Duronio
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

6.  Insulin-mediated cell proliferation and survival involve inhibition of c-Jun N-terminal kinases through a phosphatidylinositol 3-kinase- and mitogen-activated protein kinase phosphatase-1-dependent pathway.

Authors:  C Desbois-Mouthon; A Cadoret; M J Blivet-Van Eggelpoël; F Bertrand; M Caron; A Atfi; G Cherqui; J Capeau
Journal:  Endocrinology       Date:  2000-03       Impact factor: 4.736

7.  Sustained JNK activation induces endothelial apoptosis: studies with colchicine and shear stress.

Authors:  Y L Hu; S Li; J Y Shyy; S Chien
Journal:  Am J Physiol       Date:  1999-10

8.  Oncogenic Ras sensitizes cells to apoptosis by Par-4.

Authors:  A Nalca; S G Qiu; N El-Guendy; S Krishnan; V M Rangnekar
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

9.  Insulin-like growth factor-1-mediated protection from neuronal apoptosis is linked to phosphorylation of the pro-apoptotic protein BAD but not to inhibition of cytochrome c translocation in rat cerebellar neurons.

Authors:  M Gleichmann; M Weller; J B Schulz
Journal:  Neurosci Lett       Date:  2000-03-17       Impact factor: 3.046

10.  Oncogenic K-Ras and basic fibroblast growth factor prevent Fas-mediated apoptosis in fibroblasts through activation of mitogen-activated protein kinase.

Authors:  H Kazama; S Yonehara
Journal:  J Cell Biol       Date:  2000-02-07       Impact factor: 10.539

View more
  26 in total

1.  RASSF7 negatively regulates pro-apoptotic JNK signaling by inhibiting the activity of phosphorylated-MKK7.

Authors:  S Takahashi; A Ebihara; H Kajiho; K Kontani; H Nishina; T Katada
Journal:  Cell Death Differ       Date:  2010-11-19       Impact factor: 15.828

2.  Wild-type NRas and KRas perform distinct functions during transformation.

Authors:  Poppy P Fotiadou; Chiaki Takahashi; Hasan N Rajabi; Mark E Ewen
Journal:  Mol Cell Biol       Date:  2007-07-16       Impact factor: 4.272

3.  Integration of multiple signaling pathway activities resolves K-RAS/N-RAS mutation paradox in colon epithelial cell response to inflammatory cytokine stimulation.

Authors:  Pamela K Kreeger; Yufang Wang; Kevin M Haigis; Douglas A Lauffenburger
Journal:  Integr Biol (Camb)       Date:  2010-03-08       Impact factor: 2.192

4.  Ras, an actor on many stages: posttranslational modifications, localization, and site-specified events.

Authors:  Imanol Arozarena; Fernando Calvo; Piero Crespo
Journal:  Genes Cancer       Date:  2011-03

5.  Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling.

Authors:  Shiri Kfir; Marcelo Ehrlich; Ayelet Goldshmid; Xuedong Liu; Yoel Kloog; Yoav I Henis
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells.

Authors:  Nicole M Brossier; Amanda M Prechtl; Jody Fromm Longo; Stephen Barnes; Landon S Wilson; Stephanie J Byer; Stephanie N Brosius; Steven L Carroll
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

Review 7.  p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance.

Authors:  Valentina Grossi; Alessia Peserico; Tugsan Tezil; Cristiano Simone
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

8.  Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progression.

Authors:  Yufang Wang; Sérgia Velho; Efsevia Vakiani; Shouyong Peng; Adam J Bass; Gerald C Chu; Jessica Gierut; James M Bugni; Channing J Der; Mark Philips; David B Solit; Kevin M Haigis
Journal:  Cancer Discov       Date:  2012-12-28       Impact factor: 39.397

9.  Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer.

Authors:  Ines Macias-Perez; Corina Borza; Xiwu Chen; Xuexian Yan; Raquel Ibanez; Glenda Mernaugh; Lynn M Matrisian; Roy Zent; Ambra Pozzi
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

10.  RAS mutations affect tumor necrosis factor-induced apoptosis in colon carcinoma cells via ERK-modulatory negative and positive feedback circuits along with non-ERK pathway effects.

Authors:  Pamela K Kreeger; Roli Mandhana; Shannon K Alford; Kevin M Haigis; Douglas A Lauffenburger
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.